REGENERX BIOPHARMACEUTICALS INC — Form D

REGENERX BIOPHARMACEUTICALS INC of BETHESDA, MD, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-19. The offering totals $1.5M, of which $950K was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
L. THOMPSON L BOWLESDirectorROCKVILLE, MD
R. DON L ELSEYDirectorROCKVILLE, MD
J.J. FinkelsteinDirectorRockville, MD
DAVID CROCKFORDExecutive OfficerROCKVILLE, MD
C. NEIL LYONSExecutive OfficerROCKVILLE, MD
Mauro BoveDirectorSAN DIEGO, CA
J.J. FinkelsteinExecutive OfficerRockville, MD
Joseph Don McNayDirectorRockville, MD
Allan L GoldsteinDirectorRockville, MD
R. Don ElseyDirectorRockville, MD
Joseph C McNayDirectorBoston, MA
R Don ElseyDirectorRockville, MD
Mauro L BoveDirectorRockville, MD
Allan GoldsteinDirectorPurchase, NY
Joseph McNayDirectorSan Antonio, TX
L. Thompson BowlesDirectorBethesda, MD
Richard HindinDirectorBethesda, MD
Jospeh McNayDirectorBethesda, MD

Other filings by this issuer (7)

FiledFormOfferingSold
2019-03-07D$1.3M$1.3M
2018-03-19D$888K$888K
2016-07-13D$4.4M$4.4M
2011-01-19D$11.0M
2011-01-19D$518K$259K
2009-10-26D$1.0M$1.0M
2009-05-13D$600K$600K

More